Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atomera Incorporated filings document the company's semiconductor technology licensing business, Nasdaq-listed common stock, and material-event disclosures. Current reports furnish quarterly and annual financial results, investor presentations, Regulation FD communications, and capital-structure information related to common stock and registered securities.
Proxy and governance filings cover annual meeting procedures, shareholder voting matters, board and bylaw provisions, and other corporate-governance disclosures. The record also includes amendments to bylaws, including meeting quorum and voting-requirement changes, alongside formal exhibits used to report operating results, material agreements, and other public-company events.
LE DUY LOAN T reported acquisition or exercise transactions in this Form 4 filing.
Atomera Inc director LE DUY LOAN T received a grant of 14,302 shares of Common Stock as a stock-based award. The grant was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase. After this award, the director holds 134,460 shares directly. According to the footnote, these are Restricted Stock Units issued on May 12, 2026 that will vest on May 11, 2027, meaning the shares are subject to a one-year vesting period.
Gerber John reported acquisition or exercise transactions in this Form 4 filing.
Atomera Inc director John Gerber received a compensation grant of 14,302 shares of Common Stock on May 12, 2026, in the form of Restricted Stock Units that will vest on May 11, 2027. The grant carried a stated price of $0.00 per share.
After this award, Gerber directly holds 332,569 shares of Atomera Common Stock. He also has indirect holdings, including 8,900 shares held by his spouse’s IRA, 156,196 shares held by his spouse, and 37,192 shares held by a partnership.
Atomera Incorporated reported a wider first-quarter net loss while significantly strengthening its balance sheet. Revenue for the three months ended March 31, 2026 was about $11,000, up from $4,000 a year earlier, mostly from engineering services tied to MST wafer deliveries. Operating expenses rose to roughly $6.2 million, driven by higher research and development, general and administrative, and selling and marketing costs, leading to a net loss of about $6.1 million, similar on a per-share basis at $(0.17).
Cash, cash equivalents and short-term investments totaled approximately $41.1 million with working capital near $39.9 million, helped by equity financing. During the quarter Atomera raised about $23.6 million of net proceeds from a registered direct offering of 5,000,000 shares at $5.00 per share and approximately $3.1 million from selling around 1.3 million shares through its 2025 at-the-market program. Management believes existing capital can fund operations for at least 24 months while the company continues to develop and license its MST® semiconductor technology.
Atomera Incorporated reported first quarter 2026 results showing continued investment and a wider loss while strengthening its balance sheet through new equity capital.
For the quarter ended March 31, 2026, revenue was $11 thousand and net loss was $6.1 million, or $0.17 per share, compared with a $5.2 million loss a year earlier. Adjusted EBITDA loss was $4.9 million. Cash, cash equivalents and short-term investments increased to $41.1 million, helped by a completed $25 million registered direct offering of common stock, and shares outstanding rose to 38.7 million.
Management highlighted progress in moving its MST technology into evaluation with additional Gate-All-Around transistor manufacturers and expanding its GaN technology into RF applications, positioning the company to support future MST-enabled products despite current low revenue and ongoing operating losses.
Atomera Incorporated is asking stockholders to vote at its virtual 2026 annual meeting on May 12, 2026. The agenda includes electing five directors, ratifying CBIZ CPAs P.C. as independent auditor for the year ending December 31, 2026, approving an advisory “say‑on‑pay” vote for named executive officers, and a key charter amendment.
The charter amendment would increase authorized common stock from 47,500,000 to 95,000,000 shares. As of March 13, 2026, 38,722,969 common shares were outstanding, with additional shares reserved for equity awards, leaving relatively few authorized but unissued shares.
The proxy describes a board that is majority independent, with separate Audit, Compensation, and Nominating and Corporate Governance Committees and a cybersecurity subcommittee. It details an executive pay program mixing salary, performance‑based cash bonuses, time‑based and performance RSUs tied to relative total shareholder return, and new performance stock options that vest only if stock price hurdles of $7.50, $12.50 and $20.00 are sustained and time‑based conditions are met. Atomera also highlights anti‑hedging rules, an insider trading policy, stock ownership guidelines for executives, and an executive clawback policy aligned with Nasdaq and SEC rules.
The Vanguard Group amended its Schedule 13G to report beneficial ownership of Atomera Inc. common stock as 0% — 0 shares — as of 03/13/2026.
The filing states this change follows an internal realignment and disaggregation of subsidiaries under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately.
Atomera Incorporated has filed a preliminary proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on May 12, 2026. The meeting agenda includes: election of five directors, ratification of CBIZ CPAs P.C. as independent auditors, a proposal to increase authorized common stock to 95,000,000 shares, and a non-binding advisory vote on executive compensation.
The proxy materials state a record date of March 13, 2026 and report 38,722,969 shares outstanding as of that date. The board recommends votes FOR each management proposal. The proxy is being distributed beginning on or about March 31, 2026.
Atomera Inc reported that Chief Technology Officer Robert J. Mears received new performance-based stock option grants covering a total of 131,472 shares of common stock at an exercise price of $5.10 per share, expiring on March 11, 2036.
Each grant vests only if both time and stock price targets are achieved. The first 25% is scheduled to vest on March 1, 2027, with the remainder vesting in 12 equal quarterly installments. For each tranche, vesting also requires that the average volume-weighted stock price over any 30 consecutive trading days within five years of grant meets separate hurdles of $7.50, $12.50, or $20.00. If a given price threshold is not reached within five years, the related options will not vest and will terminate, and there were no open-market purchases or sales in this filing.
Atomera Inc CFO Laurencio Francis reported receiving three performance-based stock option grants on March 11, 2026. Each option has an exercise price of $5.10 and covers underlying shares of Atomera common stock in blocks of 78,888, 39,444 and 39,444 options.
The awards vest based on both time and share price performance. For each grant, 25% is scheduled to vest on March 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. However, vesting occurs only if the average volume-weighted share price over any 30 consecutive trading days within five years reaches specific thresholds of $7.50, $12.50, or $20.00, depending on the grant. If a grant’s price hurdle is not met within five years, none of its options vest and they terminate.